Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Agerafenib hydrochloride is a highly potent inhibitor of BRAFV600E (Kd: 14 nM).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | Inquiry | $ 1,520.00 |
Description | Agerafenib hydrochloride is a highly potent inhibitor of BRAFV600E (Kd: 14 nM). |
Targets&IC50 | BRAF:36 nM (kd), B-Raf (V600E):14 nM (kd), c-Kit:2 nM (kd), JAK2:4700 nM (kd), Raf:39 nM (kd), EGFR:22 nM (kd), VEGFR2:8 nM (kd), MEK2:8300 nM (kd), EphA2:14 nM (kd), CSF1R:9 nM (kd), Abl-1:3 nM (kd), MEK1:7100 nM (kd), Lck:2 nM (kd), RET:2 nM (kd), c-Met:513 nM (kd) |
In vitro | Agerafenib exhibits high potency against several BRAF V600E-dependent cell lines and selective cytotoxicity for tumor cell lines expressing mutant BRAF V600E. It shows potent binding (BRAF V600E, Kd: 14 nM) and cellular activity (pMEK IC50=82 nM and A375 proliferation IC50=78 nM), with activity in the proliferation assay. Agerafenib also exhibits a favorable CYP450 inhibition profile, with measured IC50 values greater than 10 μM versus the CYP1A2, CYP2C9, CYP2D6, and CYP3A4 isoforms and an IC50=3.4 μM versus CYP2C19. |
In vivo | Agerafenib exhibits an exceptional PK profile in mouse, dog, and cynomolgus monkey. Administration of Agerafenib to beagle dogs (single dose of 1 mg/kg i.v and 10 mg/kg p.o) results in low clearance (CL=5.0 (mL/min)/kg) and excellent bioavailability (%F=100). Similarly, in cynomolgus monkey, the administration of Agerafenib (single dose of 1 mg/kg i.v and 10 mg/kg p.o) leads to high oral exposure due to low clearance (CL=6.7 mL/min/kg) and excellent bioavailability (%F=100). Oral administration of Agerafenib to Colo-205 tumor xenograft-bearing mice results in significant inhibition of pMEK in tumor cell lysates. |
Synonyms | RXDX-105 hydrochloride, CEP-32496 (hydrochloride) |
Molecular Weight | 553.92 |
Formula | C24H23ClF3N5O5 |
CAS No. | 1227678-26-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Agerafenib hydrochloride 1227678-26-3 Apoptosis Tyrosine Kinase/Adaptors c-RET c-Kit RXDX105 Hydrochloride CEP 32496 CEP-32496 RXDX-105 hydrochloride RXDX 105 Hydrochloride CEP32496 RXDX-105 Hydrochloride Agerafenib Hydrochloride CEP-32496 (hydrochloride) inhibitor inhibit